275 related articles for article (PubMed ID: 15353488)
1. Differential effects of apolipoprotein A-I-mimetic peptide on evolving and established atherosclerosis in apolipoprotein E-null mice.
Li X; Chyu KY; Faria Neto JR; Yano J; Nathwani N; Ferreira C; Dimayuga PC; Cercek B; Kaul S; Shah PK
Circulation; 2004 Sep; 110(12):1701-5. PubMed ID: 15353488
[TBL] [Abstract][Full Text] [Related]
2. Reverse D4F, an apolipoprotein-AI mimetic peptide, inhibits atherosclerosis in ApoE-null mice.
Qin S; Kamanna VS; Lai JH; Liu T; Ganji SH; Zhang L; Bachovchin WW; Kashyap ML
J Cardiovasc Pharmacol Ther; 2012 Sep; 17(3):334-43. PubMed ID: 22308547
[TBL] [Abstract][Full Text] [Related]
3. Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice.
Faria-Neto JR; Chyu KY; Li X; Dimayuga PC; Ferreira C; Yano J; Cercek B; Shah PK
Atherosclerosis; 2006 Nov; 189(1):83-90. PubMed ID: 16386745
[TBL] [Abstract][Full Text] [Related]
4. Gene transfer of a broad spectrum CC-chemokine inhibitor reduces vein graft atherosclerosis in apolipoprotein E-knockout mice.
Ali ZA; Bursill CA; Hu Y; Choudhury RP; Xu Q; Greaves DR; Channon KM
Circulation; 2005 Aug; 112(9 Suppl):I235-41. PubMed ID: 16159823
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E mimetic is more effective than apolipoprotein A-I mimetic in reducing lesion formation in older female apo E null mice.
Nayyar G; Garber DW; Palgunachari MN; Monroe CE; Keenum TD; Handattu SP; Mishra VK; Anantharamaiah GM
Atherosclerosis; 2012 Oct; 224(2):326-31. PubMed ID: 22771190
[TBL] [Abstract][Full Text] [Related]
6. Endothelial overexpression of Fas ligand decreases atherosclerosis in apolipoprotein E-deficient mice.
Yang J; Sato K; Aprahamian T; Brown NJ; Hutcheson J; Bialik A; Perlman H; Walsh K
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1466-73. PubMed ID: 15178561
[TBL] [Abstract][Full Text] [Related]
7. Broad-spectrum CC-chemokine blockade by gene transfer inhibits macrophage recruitment and atherosclerotic plaque formation in apolipoprotein E-knockout mice.
Bursill CA; Choudhury RP; Ali Z; Greaves DR; Channon KM
Circulation; 2004 Oct; 110(16):2460-6. PubMed ID: 15477414
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice.
Chyu KY; Babbidge SM; Zhao X; Dandillaya R; Rietveld AG; Yano J; Dimayuga P; Cercek B; Shah PK
Circulation; 2004 May; 109(20):2448-53. PubMed ID: 15136500
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein A-I Mimetic Peptides: Discordance Between In Vitro and In Vivo Properties-Brief Report.
Ditiatkovski M; Palsson J; Chin-Dusting J; Remaley AT; Sviridov D
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1301-1306. PubMed ID: 28522696
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein A-I protection against atherosclerosis is dependent on genetic background.
Sontag TJ; Krishack PA; Lukens JR; Bhanvadia CV; Getz GS; Reardon CA
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):262-9. PubMed ID: 24334873
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice.
Wassmann S; Czech T; van Eickels M; Fleming I; Böhm M; Nickenig G
Circulation; 2004 Nov; 110(19):3062-7. PubMed ID: 15277329
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels.
Raffai RL; Loeb SM; Weisgraber KH
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):436-41. PubMed ID: 15591220
[TBL] [Abstract][Full Text] [Related]
13. Topical HDL administration reduces vein graft atherosclerosis in apo E deficient mice.
Feng Y; Gordts SC; Chen F; Hu Y; Van Craeyveld E; Jacobs F; Carlier V; Feng Y; Zhang Z; Xu Q; Ni Y; De Geest B
Atherosclerosis; 2011 Feb; 214(2):271-8. PubMed ID: 20943224
[TBL] [Abstract][Full Text] [Related]
14. Chronic infusion of salusin-alpha and -beta exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice.
Nagashima M; Watanabe T; Shiraishi Y; Morita R; Terasaki M; Arita S; Hongo S; Sato K; Shichiri M; Miyazaki A; Hirano T
Atherosclerosis; 2010 Sep; 212(1):70-7. PubMed ID: 20684826
[TBL] [Abstract][Full Text] [Related]
15. Reverse apolipoprotein A-I mimetic peptide R-D4F inhibits neointimal formation following carotid artery ligation in mice.
Du L; Qu X; Zheng H; Li R; Wang J; Chen M; Zhao P; Zhang Z; Gong K
Am J Pathol; 2013 May; 182(5):1932-9. PubMed ID: 23499549
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of accelerated atherosclerosis in vein grafts by placement of external stent in apoE*3-Leiden transgenic mice.
Lardenoye JH; De Vries MR; Grimbergen JM; Havekes LM; Knaapen MW; Kockx MM; van Hinsbergh VW; van Bockel JH; Quax PH
Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1433-8. PubMed ID: 12231562
[TBL] [Abstract][Full Text] [Related]
17. EphA2 knockdown attenuates atherosclerotic lesion development in ApoE(-/-) mice.
Jiang H; Li X; Zhang X; Liu Y; Huang S; Wang X
Cardiovasc Pathol; 2014; 23(3):169-74. PubMed ID: 24561077
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein A-I mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a murine model of diabetes.
Morgantini C; Imaizumi S; Grijalva V; Navab M; Fogelman AM; Reddy ST
Diabetes; 2010 Dec; 59(12):3223-8. PubMed ID: 20826564
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin deficiency attenuates atherosclerosis in female apolipoprotein E-deficient mice.
Matsui Y; Rittling SR; Okamoto H; Inobe M; Jia N; Shimizu T; Akino M; Sugawara T; Morimoto J; Kimura C; Kon S; Denhardt D; Kitabatake A; Uede T
Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1029-34. PubMed ID: 12730087
[TBL] [Abstract][Full Text] [Related]
20. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]